Cosmos Health (COSM) Expected to Announce Quarterly Earnings on Friday

Cosmos Health (NASDAQ:COSM) will likely be issuing its results after the market closes on Friday, April 10th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $18.8210 million for the quarter.

Cosmos Health Trading Down 3.6%

Shares of NASDAQ:COSM opened at $0.30 on Wednesday. Cosmos Health has a 52 week low of $0.28 and a 52 week high of $1.32. The company’s 50 day moving average is $0.38 and its two-hundred day moving average is $0.60. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. The company has a market cap of $11.17 million, a PE ratio of -0.40 and a beta of 5.33.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Cosmos Health currently has an average rating of “Sell”.

Insider Activity at Cosmos Health

In related news, CEO Grigorios Siokas bought 388,532 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The shares were purchased at an average cost of $0.37 per share, with a total value of $143,756.84. Following the transaction, the chief executive officer directly owned 8,861,914 shares of the company’s stock, valued at approximately $3,278,908.18. This represents a 4.59% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders have purchased 1,886,310 shares of company stock valued at $844,881. Corporate insiders own 25.10% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. XTX Topco Ltd grew its position in shares of Cosmos Health by 52.1% in the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after buying an additional 34,117 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of Cosmos Health by 260.5% in the 4th quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock valued at $167,000 after buying an additional 241,775 shares during the last quarter. Finally, Citadel Advisors LLC grew its position in shares of Cosmos Health by 133.1% in the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after buying an additional 128,776 shares during the last quarter. 12.61% of the stock is owned by hedge funds and other institutional investors.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.